Asherman's Syndrome disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Asherman's Syndrome

MalaCards integrated aliases for Asherman's Syndrome:

Name: Asherman's Syndrome ¹⁹ ⁷⁵

Asherman Syndrome ¹⁹ ⁵⁸ ⁷¹

Intrauterine Adhesions ⁷¹

Intrauterine Synechiae ¹⁹

Adhesions of Uterus ⁷¹

Uterine Synechiae ¹⁹

Characteristics:

Prevelance:

Asherman Syndrome: 1-5/10000 (Europe) ⁵⁸

Age Of Onset:

Asherman Syndrome: Adult ⁵⁸

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Reproductive diseases

See all MalaCards categories (disease lists)

ICD10: ³²

Diseases of the genitourinary system

Noninflammatory disorders of female genital tract

Other noninflammatory disorders of uterus, except cervix

Intrauterine synechiae

Orphanet: ⁵⁸

Rare gynaecological and obstetric diseases

External Ids:

ICD10 via Orphanet ³² N85.6

UMLS via Orphanet ⁷² C0156372 C0241593 C1704274

Orphanet ⁵⁸ ORPHA137686

SNOMED-CT via HPO ⁶⁹ 15296000 169957005 19155002 more

UMLS ⁷¹ C0156372 C0241593 C1704274

Sources

Summaries for Asherman's Syndrome

GARD: ¹⁹ A rare, acquired uterine disease characterized by intrauterine adhesions associated with a history of curettage or intrauterine surgery and gynecological symptoms (secondary amenorrhea, hypomenorrhea, pelvic pain, infertility or pregnancy loss).

MalaCards based summary: Asherman's Syndrome, also known as asherman syndrome, is related to adhesions of uterus and amenorrhea. The drugs Dydrogesterone and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include uterus, cervix and bone marrow, and related phenotypes are oligomenorrhea and decreased fertility in females

Orphanet: ⁵⁸ A rare, acquired uterine disease characterized by intrauterine adhesions associated with a history of curettage or intrauterine surgery and gynecological symptoms (secondary amenorrhea, hypomenorrhea, pelvic pain, infertility or pregnancy loss).

Wikipedia: ⁷⁵ Asherman's syndrome (AS) is an acquired uterine condition that occurs when scar tissue (adhesions) form... more...

Sources

Related Diseases for Asherman's Syndrome

Diseases related to Asherman's Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 46)

#	Related Disease	Score
1	adhesions of uterus	10.8
2	amenorrhea	10.6
3	infertility	10.6
4	placenta accreta	10.5
5	pregnancy loss, recurrent 1	10.3
6	myoma	10.2
7	rapidly involuting congenital hemangioma	10.2
8	endometritis	10.2
9	endometriosis	10.2
10	cervical incompetence	10.2
11	endometrial cancer	10.1
12	preterm premature rupture of the membranes	10.1
13	hypogonadotropic hypogonadism	10.1
14	hydatidiform mole, recurrent, 1	10.1
15	ectopic pregnancy	10.1
16	pre-eclampsia	10.1
17	gestational trophoblastic neoplasm	10.1
18	adenomyosis	10.1
19	gestational diabetes	10.1
20	premature menopause	10.0
21	endometrial adenocarcinoma	10.0
22	hypogonadotropic hypogonadism 7 with or without anosmia	10.0
23	scoliosis	10.0
24	thrombosis	10.0
25	hypogonadism	10.0
26	thrombophilia	10.0
27	bicornuate uterus	10.0
28	adult syndrome	10.0
29	multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	10.0
30	mycobacterium tuberculosis 1	10.0
31	placenta praevia	10.0
32	schistosomiasis	10.0
33	hemometra	10.0
34	uterine inversion	10.0
35	cone-rod dystrophy 2	9.9
36	leiomyoma, uterine	9.9
37	uterine anomalies	9.9
38	intrahepatic cholestasis of pregnancy	9.9
39	oligohydramnios	9.9
40	cholestasis	9.9
41	intrahepatic cholestasis	9.9
42	gastric antral vascular ectasia	9.9
43	gastritis	9.9
44	severe combined immunodeficiency	9.9
45	placental abruption	9.9
46	septate uterus	9.9

Comorbidity relations with Asherman's Syndrome via Phenotypic Disease Network (PDN):

Adenomyosis

Myofibroma

Graphical network of the top 20 diseases related to Asherman's Syndrome:

Sources

Symptoms & Phenotypes for Asherman's Syndrome

Human phenotypes related to Asherman's Syndrome:

⁵⁸ ³⁰ (show all 12)

#	Description	HPO Frequency	Orphanet Frequency	HPO Source Accession
1	oligomenorrhea ⁵⁸ ³⁰	Frequent (33%)	Frequent (79-30%)	HP:0000876
2	decreased fertility in females ⁵⁸ ³⁰	Frequent (33%)	Frequent (79-30%)	HP:0000868
3	secondary amenorrhea ⁵⁸ ³⁰	Occasional (7.5%)	Occasional (29-5%)	HP:0000869
4	infertility ⁵⁸ ³⁰	Occasional (7.5%)	Occasional (29-5%)	HP:0000789
5	dysmenorrhea ⁵⁸ ³⁰	Occasional (7.5%)	Occasional (29-5%)	HP:0100607
6	metrorrhagia ⁵⁸ ³⁰	Occasional (7.5%)	Occasional (29-5%)	HP:0100608
7	episodic abdominal pain ⁵⁸ ³⁰	Occasional (7.5%)	Occasional (29-5%)	HP:0002574
8	chronic infection ⁵⁸ ³⁰	Very rare (1%)	Very rare (<4-1%)	HP:0031035
9	abnormal placenta morphology ³⁰	Very rare (1%)		HP:0100767
10	abnormality of the menstrual cycle ⁵⁸		Frequent (79-30%)
11	spontaneous abortion ⁵⁸		Occasional (29-5%)
12	abnormality of the placenta ⁵⁸		Very rare (<4-1%)

Sources

Drugs & Therapeutics for Asherman's Syndrome

Drugs for Asherman's Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Dydrogesterone

Approved, Investigational, Withdrawn

Phase 4

152-62-5

9051

2

Hyaluronic acid

Approved, Vet_approved

Phase 4

9004-61-9

53477741

3

Dimenhydrinate

Approved

Phase 4

523-87-5

10660

4

Estrogens

Phase 4

5

Hormone Antagonists

Phase 4

6

Contraceptive Agents

Phase 4

7

Progestins

Phase 4

8

Adjuvants, Immunologic

Phase 4

9

Viscosupplements

Phase 4

10

Immunologic Factors

Phase 4

11

Protective Agents

Phase 4

12

Pharmaceutical Solutions

Phase 4

13

Carboxymethylcellulose Sodium

Phase 4

14

Estradiol

Approved, Investigational, Vet_approved

Phase 2

50-28-2

5757

15

Polyestradiol phosphate

Approved

Phase 2

28014-46-2

16

Estrone

Approved

Phase 2

53-16-7

5870

17

Estradiol 3-benzoate

Phase 2

18

Estradiol 17 beta-cypionate

Phase 2

19

Estropipate

Phase 2

7280-37-7

20

Anticoagulants

Phase 2

21

Anti-Bacterial Agents

Phase 1

22

Anesthetics

Phase 1

23

Antibiotics, Antitubercular

Phase 1

24

Carbamide peroxide

Approved

124-43-6

25

Ethanol

Approved

Early Phase 1

64-17-5

702

26

Progesterone

Approved, Vet_approved

57-83-0

5994

27

Heparin, bovine

Approved, Investigational, Withdrawn

9005-49-6

22833565 9812414 772

28

Plerixafor

Approved

Early Phase 1

110078-46-1

65015

29

Fibrinolytic Agents

30

Calcium heparin

31

Hormones

Early Phase 1

32

Antiviral Agents

Early Phase 1

33

Anti-Retroviral Agents

Early Phase 1

34

Anti-Infective Agents

Early Phase 1

35

Anti-HIV Agents

Early Phase 1

36

Chorionic Gonadotropin

Early Phase 1

37

Ethylene

74-85-1

6325

Interventional clinical trials:

(show all 49)

#	Name	Status	NCT ID	Phase	Drugs
1	Clinical Study of the Treatment of Infertility Caused by Severe Intrauterine Adhesions by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells	Unknown status	NCT02204358	Phase 4
2	Effectiveness of Self-cross-linked Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion	Unknown status	NCT02868437	Phase 4
3	New Therapeutic Approaches to Treat Asherman's Syndrome and Endometrial Atrophy Based in BM Stem Cells Autologous Transplantation	Completed	NCT02144987	Phase 4
4	The Effect of Estrogen in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis	Enrolling by invitation	NCT03620929	Phase 4	Estradiol Valerate
5	Prevalence of Intrauterine Adhesions After the Application of Hyaluronic Acid Gel After Dilatation and Curettage in Women With Spontaneous Abortion or Induction of Abortion From 12+0 Till 23+6 Week of Pregnancy.	Not yet recruiting	NCT04671914	Phase 4	Hyaluronic Acid 20 MG/ML Injectable Solution
6	The Role of Seprafilm Bioresorbable Slurry in the Prevention of Intrauterine Synechiae in Patients Undergoing Hysteroscopic Myomectomy	Terminated	NCT01632202	Phase 4
7	Non-stick Gel Applicated After Scraping Surgery for Natural Miscarriage and Uterine Synechiae Prevention	Completed	NCT02248376	Phase 3	Gel
8	Platelet-Rich Plasma in the Management of Asherman Syndrome	Completed	NCT04308811	Phase 2
9	A Prospective, Randomized, Controlled Trial Comparing 2 Different Doses of Estrogen Therapy After Hysteroscopic Adhesiolysis as an Adjuvant to Prevent Recurrence of Intrauterine Adhesions	Completed	NCT02726971	Phase 1, Phase 2	Femoston
10	Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures	Completed	NCT03166189	Phase 2
11	Fertility Restoration Using Autologous Adipose Tissue Derived Mesenchymal Stem Cells	Completed	NCT04432467	Phase 1, Phase 2
12	Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy).	Recruiting	NCT05095597	Phase 2	Oestraclin
13	Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair: a Prospective Randomised Pilot Study	Terminated	NCT02825849	Phase 2
14	Safety and Therapeutic Effect of Human Amniotic Epithelial Cells in Severe Refractory Asherman's Syndrome	Unknown status	NCT03223454	Phase 1
15	Clinical Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Cells in the Treatment of Moderate and Severe Intrauterine Adhesions	Unknown status	NCT04232592	Phase 1
16	Cesarean Myomectomy : Safety and Risk of Intrauterine Synechiae	Completed	NCT03095014	Phase 1
17	Biomedical Study of Toxicity, Biodistribution, Expression and Cellular Characterization of Autologous CD133+ Stem Cells From Donors of Hematopoietic Progenitors (IGX1) in Murine Model With Asherman-induced Syndrome.	Unknown status	NCT03665649
18	Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery - a Prospective Double Blind Randomized Study	Unknown status	NCT01637974		INTERCOAT administration
19	Treatment of Intrauterine Adhesions and Its Distribution of Genital Tract Flora	Unknown status	NCT03731689		Intrauterine lavage therapy;Intrauterine gel-injection therapy
20	Amnion Graft for Preventing Intrauterine Adhesions Following Hysteroscopic Surgery	Unknown status	NCT02132104		Femoston
21	Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel	Unknown status	NCT02404454
22	The Efficacy and Safety of the Dried Biological Amnion Graft Following Hysteroscopic Lysis for the Prevention of Postoperative Adhesions in Patients With Intrauterine Adhesions	Unknown status	NCT02496052		estradiol valerate tablets+dydrogesterone Tablets
23	Hysteroscopy Assisted Suction Curettage for Early Pregnancy Loss: Does it Reduce Retained Products of Conception and Postoperative Intrauterine Adhesions?	Unknown status	NCT04637373
24	Platelet-rich Plasma(PRP) Prevents Recurrence of Intrauterine Adhesions	Unknown status	NCT03629132
25	Use Of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery	Unknown status	NCT01464528	Early Phase 1	Hyaluronan
26	A Multi-center, Randomized, Single-blind, Controlled Clinical Trial of Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells	Completed	NCT02680366
27	Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and Quality of Life in Women With Intrauterine Adhesion:a Randomized Controlled Trial.	Completed	NCT02746679
28	Effects of Intrauterine Platelet Rich Plasma (PRP) on Endometrium and Pregnancy Rates in Patients With Suboptimal Endometrium Undergoing Frozen Embryo Transfer	Completed	NCT04424160
29	A Randomized Clinical Trial to Assess the Efficacy of Intrauterine Balloon Compared to Intrauterine Contraceptive Device Plus Foley Catheter in the Therapy for Uterine Adhesion After Hysteroscopic Adhesiolysis	Completed	NCT02867202
30	Intercoat (Oxiplex/AP Gel) for Preventing Intrauterine Adhesions Following Operative Hysteroscopy for Suspected Retained Products of Conception - a Prospective Randomized Pilot Study	Completed	NCT01377779		Oxiplex/AP gel;Normal Saline
31	Reproductive Outcome Affected by Two Adjunctive Treatments in Patients With Infertility Due to Severe Intrauterine Adhesions.	Completed	NCT02708277
32	Prevalence of Chronic Endometritis in Severe Intrauterine Adhesions and Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine	Completed	NCT02744807
33	Clinical Study of the Treatment of Infertility Caused by Recurrent Intrauterine Adhesions by Collagen Scaffold Loaded With Umbilical Cord -Derived Mesenchymal Stem Cells (UC-MSCs)	Completed	NCT02313415
34	Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions (IUA) 3, 6 and 12 Months Following Endometrial Ablation: A Prospective Single-Center Observational Study	Completed	NCT04824430
35	The Value of Using Platelet Rich Plasma After Hysteroscopic Lysis of Severe Intrauterine Adhesions (A Randomized Controlled Trial)	Completed	NCT03541746
36	Autocrosslinked Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Bipolar Radiofrequency Endometrial Ablation: a Randomised, Controlled and Double Blind Study	Completed	NCT01829451
37	A Placebo Comparative, Evaluator Blinded, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of Medicurtain® in Patients With Hysteroscopy	Completed	NCT04638855
38	Endometrial Reconstruction by Human Regenerative Factors Derived From Platelet-Rich Plasma in Mice Models	Recruiting	NCT03249415
39	PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.	Recruiting	NCT04963179
40	The Cost-effectiveness of Anti-adhesion Treatment With HYALOBARRIER® GEL ENDO Versus no Gel Following the Removal by Hysteroscopy of Endometrial Polyps, Fibroids With Uterine Cavity Deformation, Uterine Septa, Intrauterine Adhesions or Retained Products of Conception for Improving Reproductive Outcome in Women Wishing to Become Pregnant: a Multi-centre, Parallel Group, Superiority, Double-blind, Randomized Controlled Trial	Recruiting	NCT03880435
41	Intrauterine Adhesions Prevention: the Use of Heparin Solution Compared to Application of Anti-adhesion Barrier Gel After Operative Hysteroscopy	Recruiting	NCT05257213		Heparin solution;Anti-adhesion barrier gel
42	The Value of Three-dimensional Ultrasound Applying in Pre and Postoperative Assessment and Prognosis of Intrauterine Adhesions	Recruiting	NCT04930913
43	Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions	Recruiting	NCT05003869
44	Reduction of Intrauterine Adhesions by Intrauterine Hyaluronic Acid Gel After Hysteroscopic Removal of Retained Products of Conception: Multicenter Prospective Randomized Trial	Active, not recruiting	NCT04975373		Intrauterine injection of hyaluronic acid
45	Establishment and Application of Endometrial 3D-organoid in Endometrial Injury Repair	Not yet recruiting	NCT05521932
46	Bone Marrow Derived Stem Cells Mobilization for Treatment of Asherman's Syndrome, Atrophic Endometrium, and Recurrent Implantation Failure	Not yet recruiting	NCT05343572	Early Phase 1	Plerixafor
47	Evaluation of Adhesions Formation Using Conventional Third Generation Endometrial Ablation With and Without Postoperative Application of an Intrauterine Adhesion Barrier Film	Not yet recruiting	NCT05414760
48	Prevalence of Intrauterine Adhesions After Abdominal Myomectomy	Not yet recruiting	NCT04030273
49	MONOBISY: Randomized Controlled Trial Comparing Intra Uterine Synechiae Occurence Using Bipolar Energy Compared With Monopolar Energy in Myoma Resection on Women Having Menorraghia and/or Infertility	Withdrawn	NCT02661087

Search NIH Clinical Center for Asherman's Syndrome

Sources

Genetic Tests for Asherman's Syndrome

Sources

Anatomical Context for Asherman's Syndrome

Organs/tissues related to Asherman's Syndrome:

MalaCards : Uterus, Cervix, Bone Marrow, Placenta, Bone, Endothelial

Sources

Publications for Asherman's Syndrome

Articles related to Asherman's Syndrome:

(show top 50) (show all 532)

#	Title	Authors	PMID	Year
1	Strategies for modelling endometrial diseases. ⁶²	Murphy AR...Kim JJ	36050476	2022
2	Bioengineering trends in female reproduction: a systematic review. ⁶²	Frances-Herrero E...Cervello I	35652272	2022
3	Successful live birth following hysteroscopic adhesiolysis under laparoscopic observation for Asherman's syndrome: A case report. ⁶²	Kakinuma T...Yanagida K	36405260	2022
4	Incidence and Clinical Implications of Placenta Accreta Spectrum After Treatment for Asherman Syndrome. ⁶²	Tavcar J...Morris SN	36442752	2022
5	Reproductive Outcomes and Overall Prognosis of Women with Asherman's Syndrome Undergoing IVF. ⁶²	Fouks Y...Cohen A	35970266	2022
6	Ultrasound and MRI appearance of abnormally adherent placenta in a woman with Asherman's syndrome. ⁶²	Marasciulo F...Prefumo F	35657771	2022
7	Endometrial regeneration in Asherman's syndrome and endometrial atrophy using Wharton's jelly-derived mesenchymal stem cells. ⁶²	Kaczynski JB...Rzepka JK	36196566	2022
8	First Use of a Novel Barrier Film in an Infertile Woman with Severe Asherman's Syndrome. ⁶²	Sroussi J...Benifla JL	35705163	2022
9	Effect of intrauterine ozone therapy on Asherman syndrome, an experimental rat model. ⁶²	Ergani SY...Tekin OM	36055047	2022
10	Mesenchymal stem cells to treat female infertility; future perspective and challenges: A review. ⁶²	Saeed Y...Liu X	36340664	2022
11	Platelet-Rich Plasma: A Promising Regenerative Therapy in Gynecological Disorders. ⁶²	Varghese J...Acharya N	36249659	2022
12	Endometrial preservation during resection of type II and type III submucosal fibroids. ⁶²	Vorona G...Saridogan E	36206803	2022
13	Human Endometrium-Derived Adventitial Cell Spheroid-Loaded Antimicrobial Microneedles for Uterine Regeneration. ⁶²	Li S...Ding L	35798313	2022
14	Uterine Factor Infertility, a Systematic Review. ⁶²	Sallee C...Gauthier T	36013146	2022
15	Successful Outcome in a Middle-Aged Woman With Secondary Infertility Using Donor Oocyte In Vitro Fertilization: A Case Report From a Rural Infertility Clinic. ⁶²	Shrivastava J...Shrivastava D	36081974	2022
16	Transient and Prolonged Activation of Wnt Signaling Contribute Oppositely to the Pathogenesis of Asherman's Syndrome. ⁶²	Xue X...Xu S	35955940	2022
17	Surgical uterus-preserving therapy after uterine rupture and haemorrhage due to placenta percreta in the first trimester following embolisation of the uterine arteries and B-Lynch suture in a previous pregnancy. ⁶²	Gabriel L...Meili G	35798499	2022
18	Hysteroscopic findings after laparoscopic and open myomectomy with or without uterine cavity breach: historical cohort study. ⁶²	Boudova B...Mara M	34669526	2022
19	Short and long-term reproductive outcomes after hysteroscopic adhesiolysis for infertile women. ⁶²	Baradwan S...Al-Jaroudi D	35616443	2022
20	Human Platelet-Rich Plasma Facilitates Angiogenesis to Restore Impaired Uterine Environments with Asherman's Syndrome for Embryo Implantation and Following Pregnancy in Mice. ⁶²	Kim MK...Song H	35563855	2022
21	Resectoscopic Surgery Part III: Advanced Resectoscopic Surgery. ⁶²	Wortman M	35158402	2022
22	Mesenchymal stem cell-based therapy and female infertility: limitations and advances. ⁶²	Ghajari G...Ghorbani M	35546752	2022
23	An Insight on the Role of Altered Function and Expression of Exosomes and MicroRNAs in Female Reproductive Diseases. ⁶²	Javadi M...Roshangar L	33825167	2022
24	A Patient-Centred Approach to Early Pregnancy Loss: The First 18 Months of a Canadian Outpatient Program for Early Pregnancy Loss (OPEL). ⁶²	Gregoire-Briard F...Black A	34973436	2022
25	Prenatal diagnosis of placenta accreta spectrum. ⁶²	Conturie CL...Lyell DJ	35230992	2022
26	Platelet Rich Plasma in Gynecology-Discovering Undiscovered-Review. ⁶²	Streit-Cieckiewicz D...Futyma K	35564681	2022
27	Intrauterine administration of G-CSF for promoting endometrial growth after hysteroscopic adhesiolysis: a randomized controlled trial. ⁶²	Zhang Y...Lin X	35147195	2022
28	Mesenchymal stem cells therapy: A promising method for the treatment of uterine scars and premature ovarian failure. ⁶²	Gao M...Jia R	34798583	2022
29	Surgical treatment of Asherman syndrome and reproductive outcome. ⁶²	Hansen BB...Nohr B	35244019	2022
30	Cell-based therapy in thin endometrium and Asherman syndrome. ⁶²	Gharibeh N...Ahmadian Heris J	35090547	2022
31	"Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial". ⁶²	Hoang VT...Nguyen Thanh L	36247008	2022
32	Analysis of risk factors for obstetric outcomes after hysteroscopic adhesiolysis for Asherman syndrome: A retrospective cohort study. ⁶²	Zhang Y...Lin X	33483955	2022
33	Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome: a cutting-edge approach. ⁶²	Puente Gonzalo E...Lagana AS	32514742	2021
34	Bio-modulated mice epithelial endometrial organoids by low-level laser therapy serves as an invitro model for endometrial regeneration. ⁶²	Gebril M...Elnoury MAH	34662815	2021
35	Making More Womb: Clinical Perspectives Supporting the Development and Utilization of Mesenchymal Stem Cell Therapy for Endometrial Regeneration and Infertility. ⁶²	Strug M...Aghajanova L	34945836	2021
36	Corrigendum to 'Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome' [Bioactive Mater. 6 (2021) 3935-3946]. ⁶²	Jiang X...Li Y	34095618	2021
37	Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome. ⁶²	Jiang X...Li Y	33937593	2021
38	Bioengineered endometrial hydrogels with growth factors promote tissue regeneration and restore fertility in murine models. ⁶²	Lopez-Martinez S...Cervello I	34428563	2021
39	Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience. ⁶²	Aghajanova L...Huddleston HG	34613578	2021
40	The implementation of routine procedural transvaginal sonography to decrease retained products of conception: a quality improvement initiative. ⁶²	Larish MA...Breitkopf MD	34602062	2021
41	Hysteroscopy as a Primary Tool in Exploration and Treatment of Infertility: Single Center Experience in Western Romania. ⁶²	Citu C...Citu IM	34679615	2021
42	Uterine synechiae after intrauterine device use: a case series. ⁶²	Abel MK...Noel M	33830411	2021
43	Recent Advances in Diagnosis and Management of Female Genital Tuberculosis. ⁶²	Sharma JB...Dharmendra S	34483510	2021
44	Avoiding Asherman's syndrome: refining our approach to uterine evacuation. ⁶²	Freedman MF...Schlaff WD	34330428	2021
45	Live births after Asherman syndrome treatment. ⁶²	Hanstede MMF...Emanuel MH	34130799	2021
46	Classification systems of Asherman's syndrome. An old problem with new directions. ⁶²	Manchanda R...Vitale SG	33660561	2021
47	Successful Application of Combined Autologous Bone Marrow-Derived Stem Cells and Platelet-Rich Plasma in a Case of Severe Asherman Syndrome and Subsequent in vitro Fertilization Conception. ⁶²	Tandulwadkar S...Gupta S	35197694	2021
48	Birth of a healthy infant after bone marrow-derived cell therapy. ⁶²	Patel NH...Thakkar HR	34488290	2021
49	Fertility and pregnancy complications following chorioamnionitis. ⁶²	Shai D...Nahum R	34587848	2021
50	Uterine adhesion: Is luteal phase prior to follicular phase in uterine adhesiolysis? ⁶²	Fei Y...Jiang X	34664846	2021

Sources

Genes for Asherman's Syndrome

Sources

Variations for Asherman's Syndrome

Sources

Expression for Asherman's Syndrome

Search GEO for disease gene expression data for Asherman's Syndrome.

Sources

Pathways for Asherman's Syndrome

Sources

GO Terms for Asherman's Syndrome

Sources

Sources for Asherman's Syndrome

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: ASH001 MIFTS: 36	Asherman's Syndrome Categories: Rare diseases, Reproductive diseases	Data Licensing For inquiries, contact: [email protected]
Tissues Related diseases Publications Symptoms & Phenotypes Drugs Expand all tables